// March 01, 2018
Standards are evolving to help industry produce complex, quality assured biologic medicines
Highly complex biologics such as proteins, monoclonal antibodies, and cell and gene therapies inc
Highly complex biologics such as proteins, monoclonal antibodies, and cell and gene therapies inc
Over the past three decades, our medicines have become increasingly “globalized.” In the US alone
By Patricia C. Kienle, RPh, MPA, FASHP
By: Trish Li and Edith Chang